Antisynthetase syndrome (aSS) corresponds to an overlapping
inflammatory myopathy identified by various
myositis-specific
autoantibodies (directed against
tRNA-
synthetases). Myocardial involvement in this condition is poorly described.From a registry of 352 aSS patients, 12 cases of
myocarditis were retrospectively identified on the basis of an unexplained increase in
troponin T/I levels associated with either suggestive cardiac magnetic resonance imaging (MRI) findings, nonsignificant coronary artery abnormalities or positive endomyocardial biopsy.The prevalence of
myocarditis in aSS is 3.4% and was not linked to any
autoantibody specificity: anti-Jo1 (n = 8), anti-PL7 (n = 3), and anti-PL12 (n = 1).
Myocarditis was a part of the first aSS manifestations in 42% of the cases and was asymptomatic (n = 2) or revealed by an acute (n = 4) or a subacute (n = 6)
cardiac failure. It should be noted that
myocarditis was always associated with an active
myositis. When performed (n = 11), cardiac MRI revealed a late hypersignal in the T1-images in 73% of the cases (n = 8). Half of the patients required
intensive care. Ten patients (83%) received dedicated cardiotropic drugs.
Steroids and at least 1 immunosuppressive drug were given in all cases. After a median follow-up of 11 months (range 0-84) 9 (75%) patients recovered whereas 3 (25%) developed a chronic cardiac insufficiency. No patient died.The prevalence of
myocarditis in aSS is similar to that of other
inflammatory myopathies. Although the prognosis is relatively good,
myocarditis is a severe condition and should be carefully considered as a possible manifestation in active aSS patients.